Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?

Guidelines recommended oral anticoagulant (OAC) for ischemic stroke patients related to atrial fibrillation (AF). But, underprescription or underdose of warfarin was observed worldwide. We aimed to explore if the use of antithrombotic therapy in nonvalvular AF (NVAF) ischemic stroke patients improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Pin, Tan, Teng-Yeow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635774/
https://www.ncbi.nlm.nih.gov/pubmed/26402834
http://dx.doi.org/10.1097/MD.0000000000001627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635774/
https://www.ncbi.nlm.nih.gov/pubmed/26402834
http://dx.doi.org/10.1097/MD.0000000000001627

Ejemplares similares